OKYO Pharma Limited (OKYO)

OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $94.59 million. The enterprise value is $101.11 million.

Market Cap	94.59M
Enterprise Value	101.11M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

OKYO Pharma has 37.61 million shares outstanding. The number of shares has increased by 34.57% in one year.

Current Share Class	37.61M
Shares Outstanding	37.61M
Shares Change (YoY)	+34.57%
Shares Change (QoQ)	+35.24%
Owned by Insiders (%)	33.31%
Owned by Institutions (%)	5.54%
Float	25.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-169.87%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	127.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.57M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-3.26M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.16% in the last 52 weeks. The beta is -4.20, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y)	-4.20
52-Week Price Change	+85.16%
50-Day Moving Average	2.37
200-Day Moving Average	1.48
Relative Strength Index (RSI)	45.66
Average Volume (20 Days)	145,047

Short Selling Information

The latest short interest is 92,053, so 0.24% of the outstanding shares have been sold short.

Short Interest	92,053
Short Previous Month	125,266
Short % of Shares Out	0.24%
Short % of Float	0.37%
Short Ratio (days to cover)	0.72

Income Statement

Revenue	n/a
Gross Profit	-4.84M
Operating Income	-7.09M
Pretax Income	-13.28M
Net Income	-4.71M
EBITDA	-7.09M
EBIT	-7.09M
Earnings Per Share (EPS)	-$0.12

Balance Sheet

The company has $1.56 million in cash and n/a in debt, giving a net cash position of $1.56 million or $0.04 per share.

Cash & Cash Equivalents	1.56M
Total Debt	n/a
Net Cash	1.56M
Net Cash Per Share	$0.04
Equity (Book Value)	-5.55M
Book Value Per Share	-0.15
Working Capital	-5.55M

Cash Flow

In the last 12 months, operating cash flow was -$1.81 million and capital expenditures -$1,208, giving a free cash flow of -$1.81 million.

Operating Cash Flow	-1.81M
Capital Expenditures	-1,208
Free Cash Flow	-1.81M
FCF Per Share	-$0.05

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.57%
Shareholder Yield	n/a
Earnings Yield	-4.58%
FCF Yield	-1.76%

Analyst Forecast

The average price target for OKYO Pharma is $7.00, which is 178.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	178.33%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:65.

Last Split Date	May 22, 2023
Split Type	Reverse
Split Ratio	1:65

Scores

Altman Z-Score	n/a
Piotroski F-Score	2